TherapeuticsMD, Inc. Public Float
TherapeuticsMD, Inc. (TXMD) had Public Float of $9.04 million as of 2025-06-30, per its 10-K/A filed 2026-04-01.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-01
- 2025-06-30: Entity Public Float $9.04M.
- 2024-06-30: Entity Public Float $13.41M.
- 2023-06-30: Entity Public Float $34.44M.
- 2022-06-30: Entity Public Float $87.32M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $9.04M 10-K/A · filed 2026-04-01 |
| 2024-06-30 | $13.41M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $34.44M 10-K/A · filed 2024-04-29 |
| 2022-06-30 | $87.32M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $445.00M 10-K/A · filed 2022-04-29 |
| 2020-06-30 | $307.58M 10-K · filed 2021-03-04 |
| 2019-06-30 | $539.24M 10-K/A · filed 2020-04-29 |
| 2019-06-28 | $539.24M 10-K · filed 2020-02-24 |
| 2018-06-30 | $1.14B 10-K · filed 2019-02-27 |
| 2017-06-30 | $892.90M 10-K · filed 2018-02-23 |
| 2016-06-30 | $1.38B 10-K · filed 2017-02-28 |
| 2015-06-30 | $738.93M 10-K · filed 2016-02-26 |
| 2014-06-30 | $399.62M 10-K · filed 2015-03-12 |
| 2013-06-28 | $278.46M 10-K · filed 2014-03-05 |
| 2012-06-30 | $112.97M 10-K · filed 2013-03-12 |
| 2011-06-30 | $42.51K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |